SynthesisFrontiers in medicine2026
Oxidative stress and antioxidant markers in oral leukoplakia: a systematic review and meta-analysis.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Oral leukoplakia (OLK) is a common possibly malignant condition of the oral cavity, oxidative stress (OS) are intrinsically linked to the initiation and progression of carcinogenesis. However, previous studies on the changes of various OS and antioxidant markers in patients with OLK and their diagnostic value have been inconsistent, and there is a lack of systematic comparison and evaluation. This study aims to systematically evaluate and compare the status of OS and antioxidant markers in patients with OLK versus healthy controls to identify potential biomarkers for early diagnosis. Methods: A comprehensive electronic search was conducted across PubMed, Embase, Web of Science, and the Cochrane Library to identify case-control studies investigating antioxidant and OS markers in OLK patients compared to healthy individuals from database inception to May 1, 2025. Results: Twelve studies were selected for inclusion in this meta-analysis. The analysis focused on five pro-oxidant substances and antioxidant state markers. Our findings revealed that the level of malondialdehyde (MDA) higher in patient with OLK (MD: 0.26, 95% CI: 0.22 to 0.3, Conclusion: This meta-analysis suggests that OS may be involved in the pathogenesis of OLK. The pooled analysis indicates a potential disruption of redox balance in patients with OLK. These findings provide a basis for further investigation into the mechanisms linking OS to OLK pathogenesis. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/#myprospero, CRD42025642682.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.